Proyectos de ley › 91.ª Asamblea General
Relating to a review of anti-obesity medications by the department of health and human services and the department of administrative services for purposes of the medical assistance program and health insurance plans for public employees
Temas:State governmentHealth careMedicaid
La misma legislación: SF 552
Dónde está ahora
- Hecho: Presentado18 de febrero de 2025
- Hecho: Subcomité18 de febrero de 2025
- Hecho: Comité del Senado5 de marzo de 2025
- Se saltó: Lo aprueba el SenadoSigue como SF 552
- Sigue: Comité de la Cámara
- Sigue: Lo aprueba la Cámara
- Sigue: A gobernador(a)
- Sigue: Firmado como ley
Ahora es SF 552 → Sigue avanzando con el número nuevo. Ir a SF 552 ¿Qué es el embudo (funnel)?
Qué contiene
Resumen con IA Iowa state agencies will study whether certain weight-loss medications, such as GLP-1 agonists, should be covered by public health programs and insurance for state employees. These agencies will look at how well the drugs work, their costs, and which people should be allowed to use them. A report with their findings and suggestions will be given to the state legislature by early 2026. (Todavía no está traducido al español.)1
Lea la explicación oficial (en inglés)
This bill relates to the department of health and human services (HHS) and the department of administrative services (DAS) review of anti-obesity medication for purposes of the medical assistance program and health insurance plans established pursuant to Code chapter 509A for public employees. The bill requires HHS and DAS to review anti-obesity medications, including GLP-1 agonists, for effectiveness, comorbidities, cost savings, and eligibility requirements as described in the bill. HHS and DAS shall submit a report to the general assembly by January 5, 2026, containing HHS’s and DAS’s findings and proposed eligibility requirements.
Senate subcommittee
Named February 18, 2025. On February 20, 2025 it recommended amendment and passage.
Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part
Cabildeo
2 a favor · 0 en contra · 16 indecisos · Quiénes →
Family tree
Study bill
91st General Assembly